Experience:
5+ years of experience
Concerned about your lack of experience? Learn More...
Employment Type:
Full time
Posted:
8/10/2017
Job Category:
Nursing
See more jobs for students and recent grads who studied:
Rare Disease, Family Access Manager
Biogen | New England, North Dakota
Tell Us More About Your Job Preferences
By telling us what you think of this job, we can help find jobs that match your interests. If you want to see more jobs like this, click on the smiley face. Or if this job isn't what you are looking for, click the frowny face. Learn More...

Follow This Company
Share

Job Description

Job ID:1896
Location:Southern New England, US
Category:Job.category
Overview:The purpose of this position is to be the patient facing expert on the Rare Disease patient journey and the liaison for all Biogen team members involved in the process. They are responsible for engaging cross functional stakeholders on next steps to support appropriate patients getting started and staying on therapy. The Family Access Manager (FAM) will get to the root of any logistical issues impacting treatment initiation and ongoing therapy. They are able to identify the point person to resolve the issue (AE, Market Access & Reimbursement, and/or Case Management). The FAM will have an in depth understanding of the HCP prescribing account, the administration site of care, and the payer approval process at the patient level. The FAM will provide patient education and support site of care logistics, patient facing reimbursement education, disease state and product education as well as provide emotional support for the patient and their caregivers. The FAM will interact with physicians, nurses, pharmacists, ancillary staff, patients/families, and advocacy groups to prevent and address barriers to patient access. Serve as the primary source for all regional patient advocacy activities.

Responsibilities:- Works closely with patients/families to work through the steps required to gain access to therapy (disease and product education, site of care logistics, understanding of payer policy and procedure, and other support services). - Works as the patient advocate in regular cross functional meetings with Case Manager, Account Executive, Market Access & Reimbursement to build and maintain accurate case plans for patients (e.g. case histories, insurance, on-going coverage needs etc).- Works cross functionally to identify and support the resolution of patient access barriers including insurance coverage, reimbursement, financial limitations, site of care, procurement/distribution issues. - Will work with MA&R team members who will ensure proper reimbursement, engage with payers, specialty pharmacies, and specialty distributors to ensure access. - Must be able to provide strong emotional support for the caregivers and collaborate with them in a way that allows for forward progress.- Be knowledgeable of any changes in the patient access environment to identify issues that may impact access and communicate information appropriately to patients/caregivers. - Complete a comprehensive assessment of the individual needs of the patient taking into account the patient's family and team of healthcare providers. This assessment will include understanding the individual's payer policies, plan designs, including Medicaid coverage if applicable, as well as the healthcare system local to the patient. - Develop and offer solutions to the family, when necessary, that may also include communication of alternative insurance options and how families can best connect to available resources.- Educates patients, families, and caregivers on product and all Biogen services- Develops activities with the goal of achieving greater openness and understanding of rare disease.- The FAM will also build the rare disease network/relationships through local advocacy groups, rare disease related events, and attending national conferences.- Maintains up to date knowledge on product and BIIB resources available to support patients/caregivers at the regional level and applies this knowledge in a way that supports patient care.


Qualifications:- Minimum of 5 years total business experience in the healthcare or biotech industry with at least 3 years field based experience in account management, sales, or field reimbursement. Rare disease experience a plus. - A successful track record in field reimbursement, clinical education or in pharmaceutical sales/management of products that required significant payer and reimbursement involvement.- Experience in supporting biologic therapy administered by a designated health care provider - Seasoned, mature pharmaceutical professional with a comprehensive understanding of field / patient reimbursement, charitable funding, non-profit organizations - Experience leading cross functionally and influencing without authority- Case management experience in rare disease a plus- Experience dedicated to assisting patients/caregivers- Must be familiar with relevant legal and regulatory environment in biotech industry- Strong communication and listening skills - Effective at managing complex individualized cases- Strong EQ skills- Must be comfortable spending 60% of their time traveling- Driving is an essential duty of the job; candidates must have a valid driver's license to be consideredEducation Bachelor's degree required.

About Biogen

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company's products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab) and FUMADERM (dimethylfumarate and monoethylfumarate salts). AVONEX is used in the treatment of relapsing forms of multiple sclerosis (MS). RITUXAN is used in the treatment of relapsed or refractory low-grade or follicular, CD20-positive, and B-cell, non-Hodgkin's lymphomas (B-cell NHLs). TYSABRI is approved for the treatment of relapsing forms of MS. FUMADERM acts as an immunomudulator. It also has product candidates, such as BG-12 (acquired with the purchase of Fumapharm), ANTI-CD80 antibody/(galiximab), ANTI-CD23 antibody/(lumiliximab), Ocrelizumab/(Humanized ANTI-CD20 Antibody) and Lixivaptan.In January 2007, the Company completed the acquisition of Syntonix Pharmaceuticals, Inc. (Source: 10-K)

This company profile was created by AfterCollege and is about Biogen. This page is not endorsed by or affiliated with Biogen. For questions regarding company profiles, please email: care@aftercollege.com.